Sandro Santagata

机构：Brigham and Women's Hospital, Harvard University, Massachusetts General Hospital, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Center for Systems Biology, Mass General Brigham · ORCID：0000-0002-7528-9668

发表论文 750 篇 · 总被引 35270 次 · h-index 93

代表论文

• Abemaciclib in meningiomas with somatic NF2 or CDK pathway alterations: the phase 2 Alliance A071401 trial (2026 · Nature Medicine · 被引 4)
• Porcine kidney xenotransplantation as a bridge to allotransplantation: a first-in-human study (2026 · The Lancet · 被引 2)
• A MEF2C transcription factor network regulates proliferation of glomerular endothelial cells in diabetic kidney disease (2026 · Kidney International · 被引 2)
• Epigenetic dysregulation of metabolic programs mediates liposarcoma cell plasticity (2026 · Science Translational Medicine · 被引 2)
• In vivo evidence for bleb-induced survival signaling in metastatic melanoma (2026 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 2)
• Antibody-drug conjugates for primary brain tumors (2026 · Frontiers in Oncology · 被引 1)